Depression linked to higher amygdala-to-cortex activity ratio, lower heart rate variability, higher C-reactive protein.
BioAge’s NLRP3 inhibitor has shown potential to reduce high-sensitivity C-reactive protein (hsCRP), a key marker of ...
“This publication validates our belief that precision medicine should be measured, not marketed,” said Katy Whalen, ...
"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors.
Anti-inflammatory treatment reduced depressive symptoms and anhedonia in patients with elevated inflammation. Learn more.
Dr Vishakha shares some blood tests that can help men monitor and maintain their optimal health, detect potential issues ...
After a year of significant disruption at Novo Nordisk, the company's R&D chief has told Fierce Biotech that the deal-hungry ...
Investing.com -- BioAge Labs, Inc. (NASDAQ:BIOA) stock surged 21% Monday after the clinical-stage biopharmaceutical company announced additional positive interim data from its Phase 1 trial of BGE-102 ...
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a late-stage life sciences company focused on advancing ...
Investor's Business Daily on MSN
BioAge rockets as it takes on Eli Lilly's takeover play, Ventyx Bio
BioAge shares catapulted Monday on promising results for the company's cardiovascular diseases treatment, which could ...
Q: I heard about a Million Pound Challenge that was launched at the What’s Next Longevity Innovation Summit last December.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results